IGMS
Price
$1.32
Change
+$0.08 (+6.45%)
Updated
Jun 6 closing price
Capitalization
74.84M
65 days until earnings call
OKYO
Price
$1.90
Change
+$0.04 (+2.15%)
Updated
Jun 6 closing price
Capitalization
64.48M
59 days until earnings call
Interact to see
Advertisement

IGMS vs OKYO

Header iconIGMS vs OKYO Comparison
Open Charts IGMS vs OKYOBanner chart's image
IGM Biosciences
Price$1.32
Change+$0.08 (+6.45%)
Volume$369.87K
Capitalization74.84M
OKYO Pharma
Price$1.90
Change+$0.04 (+2.15%)
Volume$42.88K
Capitalization64.48M
IGMS vs OKYO Comparison Chart
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. OKYO commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a StrongBuy and OKYO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (IGMS: $1.32 vs. OKYO: $1.90)
Brand notoriety: IGMS and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 210% vs. OKYO: 37%
Market capitalization -- IGMS: $74.84M vs. OKYO: $64.48M
IGMS [@Biotechnology] is valued at $74.84M. OKYO’s [@Biotechnology] market capitalization is $64.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, OKYO is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 5 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • IGMS’s TA Score: 5 bullish, 4 bearish.
  • OKYO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both IGMS and OKYO are a good buy in the short-term.

Price Growth

IGMS (@Biotechnology) experienced а +3.94% price change this week, while OKYO (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 11, 2025.

OKYO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGMS($74.8M) has a higher market cap than OKYO($64.5M). OKYO YTD gains are higher at: 65.232 vs. IGMS (-78.396).
IGMSOKYOIGMS / OKYO
Capitalization74.8M64.5M116%
EBITDA-199.47MN/A-
Gain YTD-78.39665.232-120%
P/E RatioN/AN/A-
Revenue2.68MN/A-
Total Cash184MN/A-
Total Debt45.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
IGMSOKYO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFWM5.300.20
+3.92%
First Foundation
BKNG5614.6153.69
+0.97%
Booking Holdings
EYE21.030.17
+0.81%
National Vision Holdings
HQY111.55-1.15
-1.02%
HealthEquity
HLP0.85-0.05
-5.63%
Hongli Group

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+6.45%
MRSN - IGMS
56%
Loosely correlated
+4.78%
DYN - IGMS
50%
Loosely correlated
+5.08%
CRNX - IGMS
48%
Loosely correlated
+2.13%
MDGL - IGMS
42%
Loosely correlated
+1.51%
ATXS - IGMS
41%
Loosely correlated
+14.75%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+2.15%
XRTX - OKYO
29%
Poorly correlated
N/A
IGMS - OKYO
26%
Poorly correlated
+6.45%
SANA - OKYO
26%
Poorly correlated
+11.37%
ARCT - OKYO
25%
Poorly correlated
+7.39%
ATAI - OKYO
25%
Poorly correlated
-2.82%
More